List of Tables

Table 1. Attention Deficit and Hyperactivity Disorder Consumption Value & CAGR: China VS Global, 2020-2031, US$ Million

Table 2. Attention Deficit and Hyperactivity Disorder Market Restraints

Table 3. Attention Deficit and Hyperactivity Disorder Market Trends

Table 4. Attention Deficit and Hyperactivity Disorder Industry Policy

Table 5. Global Attention Deficit and Hyperactivity Disorder Revenue by Company, 2020-2025, US$ million, Ranked Based on Revenue in 2024

Table 6. Global Attention Deficit and Hyperactivity Disorder Revenue Share by Company, 2020-2025, Ranked by Data of 2024

Table 7. Global Attention Deficit and Hyperactivity Disorder Manufacturers Market Concentration Ratio (CR3 and HHI)

Table 8. Global Attention Deficit and Hyperactivity Disorder Mergers & Acquisitions, Expansion Plans

Table 9. Global Attention Deficit and Hyperactivity Disorder Major Companies Product Type

Table 10. Head Office and Area Served of Key Players

Table 11. China Attention Deficit and Hyperactivity Disorder Revenue by Company, 2020-2025, US$ million, Ranked Based on Revenue in 2024

Table 12. China Attention Deficit and Hyperactivity Disorder Revenue Market Share by Company, 2020-2025

Table 13. Global Key Players of Attention Deficit and Hyperactivity Disorder Upstream (Raw Materials)

Table 14. Global Attention Deficit and Hyperactivity Disorder Typical Customers

Table 15. Attention Deficit and Hyperactivity Disorder Typical Distributors

Table 16. by Type, Global Attention Deficit and Hyperactivity Disorder Consumption Value & CAGR, 2020 VS 2024 VS 2031, US$ Million

Table 17. by Application, Global Attention Deficit and Hyperactivity Disorder Consumption Value & CAGR, 2020 VS 2024 VS 2031, US$ Million

Table 18. By Region, Global Attention Deficit and Hyperactivity Disorder Consumption Value, 2020 VS 2024 VS 2031, US$ Million

Table 19. By Region, Global Attention Deficit and Hyperactivity Disorder Consumption Value, 2020-2031, US$ Million

Table 20. By Country, Global Attention Deficit and Hyperactivity Disorder Consumption Value & CAGR, 2020 VS 2024 VS 2031, US$ Million

Table 21. By Country, Global Attention Deficit and Hyperactivity Disorder Consumption Value, 2020-2031, US$ Million

Table 22. By Country, Global Attention Deficit and Hyperactivity Disorder Consumption Value Market Share, 2020-2031

Table 23. Takeda Company Information, Head Office, Market Area, and Industry Position

Table 24. Takeda Company Profile and Main Business

Table 25. Takeda Attention Deficit and Hyperactivity Disorder Models, Specifications, and Application

Table 26. Takeda Attention Deficit and Hyperactivity Disorder Revenue and Gross Margin, US$ Million, 2020-2025

Table 27. Takeda Recent Developments

Table 28. Johnson & Johnson Company Information, Head Office, Market Area, and Industry Position

Table 29. Johnson & Johnson Company Profile and Main Business

Table 30. Johnson & Johnson Attention Deficit and Hyperactivity Disorder Models, Specifications, and Application

Table 31. Johnson & Johnson Attention Deficit and Hyperactivity Disorder Revenue and Gross Margin, US$ Million, 2020-2025

Table 32. Johnson & Johnson Recent Developments

Table 33. Novartis Company Information, Head Office, Market Area, and Industry Position

Table 34. Novartis Company Profile and Main Business

Table 35. Novartis Attention Deficit and Hyperactivity Disorder Models, Specifications, and Application

Table 36. Novartis Attention Deficit and Hyperactivity Disorder Revenue and Gross Margin, US$ Million, 2020-2025

Table 37. Novartis Recent Developments

Table 38. Eli Lilly Company Information, Head Office, Market Area, and Industry Position

Table 39. Eli Lilly Company Profile and Main Business

Table 40. Eli Lilly Attention Deficit and Hyperactivity Disorder Models, Specifications, and Application

Table 41. Eli Lilly Attention Deficit and Hyperactivity Disorder Revenue and Gross Margin, US$ Million, 2020-2025

Table 42. Eli Lilly Recent Developments

Table 43. Tris Pharma Company Information, Head Office, Market Area, and Industry Position

Table 44. Tris Pharma Company Profile and Main Business

Table 45. Tris Pharma Attention Deficit and Hyperactivity Disorder Models, Specifications, and Application

Table 46. Tris Pharma Attention Deficit and Hyperactivity Disorder Revenue and Gross Margin, US$ Million, 2020-2025

Table 47. Tris Pharma Recent Developments

Table 48. Neos Therapeutics Company Information, Head Office, Market Area, and Industry Position

Table 49. Neos Therapeutics Company Profile and Main Business

Table 50. Neos Therapeutics Attention Deficit and Hyperactivity Disorder Models, Specifications, and Application

Table 51. Neos Therapeutics Attention Deficit and Hyperactivity Disorder Revenue and Gross Margin, US$ Million, 2020-2025

Table 52. Neos Therapeutics Recent Developments

Table 53. Mallinckrodt Company Information, Head Office, Market Area, and Industry Position

Table 54. Mallinckrodt Company Profile and Main Business

Table 55. Mallinckrodt Attention Deficit and Hyperactivity Disorder Models, Specifications, and Application

Table 56. Mallinckrodt Attention Deficit and Hyperactivity Disorder Revenue and Gross Margin, US$ Million, 2020-2025

Table 57. Mallinckrodt Recent Developments

Table 58. Amneal Pharmaceuticals Company Information, Head Office, Market Area, and Industry Position

Table 59. Amneal Pharmaceuticals Company Profile and Main Business

Table 60. Amneal Pharmaceuticals Attention Deficit and Hyperactivity Disorder Models, Specifications, and Application

Table 61. Amneal Pharmaceuticals Attention Deficit and Hyperactivity Disorder Revenue and Gross Margin, US$ Million, 2020-2025

Table 62. Amneal Pharmaceuticals Recent Developments

Table 63. Noven Pharmaceuticals Company Information, Head Office, Market Area, and Industry Position

Table 64. Noven Pharmaceuticals Company Profile and Main Business

Table 65. Noven Pharmaceuticals Attention Deficit and Hyperactivity Disorder Models, Specifications, and Application

Table 66. Noven Pharmaceuticals Attention Deficit and Hyperactivity Disorder Revenue and Gross Margin, US$ Million, 2020-2025

Table 67. Noven Pharmaceuticals Recent Developments

Table 68. Purdue Parma Company Information, Head Office, Market Area, and Industry Position

Table 69. Purdue Parma Company Profile and Main Business

Table 70. Purdue Parma Attention Deficit and Hyperactivity Disorder Models, Specifications, and Application

Table 71. Purdue Parma Attention Deficit and Hyperactivity Disorder Revenue and Gross Margin, US$ Million, 2020-2025

Table 72. Purdue Parma Recent Developments

List of Figures

Figure 1. Attention Deficit and Hyperactivity Disorder Picture

Figure 2. Global Attention Deficit and Hyperactivity Disorder Consumption Value, (US$ million) & (2020-2031)

Figure 3. China Attention Deficit and Hyperactivity Disorder Consumption Value, (US$ million) & (2020-2031)

Figure 4. By Consumption Value, China Attention Deficit and Hyperactivity Disorder Market Share of Global, 2020-2031

Figure 5. Global Attention Deficit and Hyperactivity Disorder Market Share by Company, (Tier 1, Tier 2, and Tier 3), 2024

Figure 6. China Attention Deficit and Hyperactivity Disorder Key Participants, Market Share, 2024

Figure 7. Attention Deficit and Hyperactivity Disorder Industry Chain

Figure 8. Attention Deficit and Hyperactivity Disorder Procurement Model

Figure 9. Attention Deficit and Hyperactivity Disorder Sales Model

Figure 10. Attention Deficit and Hyperactivity Disorder Sales Channels, Direct Sales, and Distribution

Figure 11. Stimulant

Figure 12. Non-stimulant

Figure 13. by Type, Global Attention Deficit and Hyperactivity Disorder Consumption Value, 2020-2031, US$ Million

Figure 14. by Type, Global Attention Deficit and Hyperactivity Disorder Consumption Value Market Share, 2020-2031

Figure 15. Hospital

Figure 16. Retail Pharmacy

Figure 17. Others

Figure 18. by Application, Global Attention Deficit and Hyperactivity Disorder Consumption Value, 2020-2031, US$ Million

Figure 19. by Application, Global Attention Deficit and Hyperactivity Disorder Revenue Market Share, 2020-2031

Figure 20. By Region, Global Attention Deficit and Hyperactivity Disorder Consumption Value Market Share, 2020-2031

Figure 21. North America Attention Deficit and Hyperactivity Disorder Consumption Value & Forecasts, 2020-2031, US$ Million

Figure 22. By Country, North America Attention Deficit and Hyperactivity Disorder Consumption Value Market Share, 2024

Figure 23. Europe Attention Deficit and Hyperactivity Disorder Consumption Value & Forecasts, 2020-2031, US$ Million

Figure 24. By Country, Europe Attention Deficit and Hyperactivity Disorder Consumption Value Market Share, 2024

Figure 25. Asia Pacific Attention Deficit and Hyperactivity Disorder Consumption Value & Forecasts, 2020-2031, US$ Million

Figure 26. By Country/Region, Asia Pacific Attention Deficit and Hyperactivity Disorder Consumption Value Market Share, 2024

Figure 27. South America Attention Deficit and Hyperactivity Disorder Consumption Value & Forecasts, 2020-2031, US$ Million

Figure 28. By Country, South America Attention Deficit and Hyperactivity Disorder Consumption Value Market Share, 2024

Figure 29. Middle East & Africa Attention Deficit and Hyperactivity Disorder Consumption Value & Forecasts, 2020-2031, US$ Million

Figure 30. United States Attention Deficit and Hyperactivity Disorder Consumption Value, 2020-2031, US$ Million

Figure 31. by Type, United States Attention Deficit and Hyperactivity Disorder Consumption Value Market Share, 2024 VS 2031

Figure 32. by Application, United States Attention Deficit and Hyperactivity Disorder Consumption Value Market Share, 2024 VS 2031

Figure 33. Europe Attention Deficit and Hyperactivity Disorder Consumption Value, 2020-2031, US$ Million

Figure 34. by Type, Europe Attention Deficit and Hyperactivity Disorder Consumption Value Market Share, 2024 VS 2031

Figure 35. by Application, Europe Attention Deficit and Hyperactivity Disorder Consumption Value Market Share, 2024 VS 2031

Figure 36. China Attention Deficit and Hyperactivity Disorder Consumption Value, 2020-2031, US$ Million

Figure 37. by Type, China Attention Deficit and Hyperactivity Disorder Consumption Value Market Share, 2024 VS 2031

Figure 38. by Application, China Attention Deficit and Hyperactivity Disorder Consumption Value Market Share, 2024 VS 2031

Figure 39. Japan Attention Deficit and Hyperactivity Disorder Consumption Value, 2020-2031, US$ Million

Figure 40. by Type, Japan Attention Deficit and Hyperactivity Disorder Consumption Value Market Share, 2024 VS 2031

Figure 41. by Application, Japan Attention Deficit and Hyperactivity Disorder Consumption Value Market Share, 2024 VS 2031

Figure 42. South Korea Attention Deficit and Hyperactivity Disorder Consumption Value, 2020-2031, US$ Million

Figure 43. by Type, South Korea Attention Deficit and Hyperactivity Disorder Consumption Value Market Share, 2024 VS 2031

Figure 44. by Application, South Korea Attention Deficit and Hyperactivity Disorder Consumption Value Market Share, 2024 VS 2031

Figure 45. Southeast Asia Attention Deficit and Hyperactivity Disorder Consumption Value, 2020-2031, US$ Million

Figure 46. by Type, Southeast Asia Attention Deficit and Hyperactivity Disorder Consumption Value Market Share, 2024 VS 2031

Figure 47. by Application, Southeast Asia Attention Deficit and Hyperactivity Disorder Consumption Value Market Share, 2024 VS 2031

Figure 48. India Attention Deficit and Hyperactivity Disorder Consumption Value, 2020-2031, US$ Million

Figure 49. by Type, India Attention Deficit and Hyperactivity Disorder Consumption Value Market Share, 2024 VS 2031

Figure 50. by Application, India Attention Deficit and Hyperactivity Disorder Consumption Value Market Share, 2024 VS 2031

Figure 51. Middle East & Africa Attention Deficit and Hyperactivity Disorder Consumption Value, 2020-2031, US$ Million

Figure 52. by Type, Middle East & Africa Attention Deficit and Hyperactivity Disorder Consumption Value Market Share, 2024 VS 2031

Figure 53. by Application, Middle East & Africa Attention Deficit and Hyperactivity Disorder Consumption Value Market Share, 2024 VS 2031

Figure 54. Research Methodology

Figure 55. Breakdown of Primary Interviews

Figure 56. Bottom-up Approaches

Figure 57. Top-down Approaches